Walleye Trading
PARN

Walleye Trading’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Walleye Trading’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-500
Closed – – 5554
2016
Q4 		$0 Hold
500
– – ﹤0.01% 5640
2016
Q3 		$1K Hold
500
– – ﹤0.01% 4753
2016
Q2 		$1K Buy
+500
New +$919 ﹤0.01% 5243
2016
Q1 		– Sell
-200
Closed -$1K – 6360
2015
Q4 		$1K Buy
+200
New +$761 ﹤0.01% 5196

Other funds holding PARN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Walleye Trading's PARN Position: Q1 2017 in Review

Walleye Trading sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 500 shares.

Walleye Trading first reported a position in PARN in Q4 2015 and held it in 4 quarters. The position peaked at $1K in Q3 2016. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

  • Walleye Trading reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
  • Walleye Trading sold 500 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017.
  • Walleye Trading first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q4 2015 and held it in 4 quarters.
  • Walleye Trading's Parnell Pharmaceuticals Holdings Ltd position peaked at $1K in Q3 2016.
  • 2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Walleye Trading's 13F filing for Q1 2017, filed 15 May 2017.